The CC2D2A gene plays a crucial role in the development and function of cell structures that are vital for sensory perception and cell signaling. Mutations in this gene are linked to Joubert syndrome type 9, a rare genetic disorder characterized by the malformation of the cerebellum and brain stem, leading to a range of symptoms including coordination and developmental delays, abnormal eye movements, and breathing irregularities.
To diagnose this condition, a genetic test targeting the CC2D2A gene can be performed. This test involves analyzing the DNA to identify mutations in the CC2D2A gene that are indicative of Joubert syndrome type 9. It is a critical step for families seeking answers about this condition, as it can confirm a diagnosis and help in the management and treatment planning for affected individuals.
In the UAE, DNA Labs UAE offers this specific genetic test for Joubert syndrome type 9. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring accurate and reliable results for patients and their families. This test is an essential resource for those affected by or at risk of Joubert syndrome type 9, providing them with crucial information for their health management.
The "CIC Gene Intellectual Disability Nonsyndromic CIC Related Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the CIC gene that are associated with nonsyndromic intellectual disability. The CIC gene plays a critical role in brain development and function, and mutations in this gene can lead to various neurological and developmental issues, primarily intellectual disability that does not accompany other syndromic features. This test is particularly important for families with a history of intellectual disability or for individuals showing related symptoms, as it can provide a definitive genetic diagnosis.
Performed using advanced genomic sequencing technologies, this test scrutinizes the CIC gene for any abnormalities or mutations that might be responsible for the condition. Early detection through this genetic test can be crucial for the management and treatment of the condition, allowing for tailored interventions and support to improve the quality of life for those affected.
The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the CIC gene. Conducted at DNA Labs UAE, a leading facility in genetic testing, clients are assured of precise results, confidentiality, and comprehensive support throughout the testing process. This test represents a significant step forward in the personalized diagnosis and management of intellectual disabilities, offering hope and answers to affected individuals and their families.
The CNKSR2 gene is associated with a form of intellectual disability known as nonsyndromic CNKSR2-related intellectual disability. This condition is characterized by developmental delays, speech and language impairments, and, in some cases, seizures. It is a genetic disorder that arises due to mutations in the CNKSR2 gene, which plays a crucial role in brain development and function.
To diagnose this condition, genetic testing is available at DNA Labs UAE, a facility equipped with advanced diagnostic technologies. The test specifically looks for mutations in the CNKSR2 gene that are known to cause the disorder. It is a critical step for families seeking answers about developmental issues in their children, as it can confirm the diagnosis and help guide management and intervention strategies.
The cost of the CNKSR2 gene intellectual disability nonsyndromic CNKSR2-related genetic test at DNA Labs UAE is 4400 AED. This investment includes the cost of the genetic analysis and the expertise required to interpret the results accurately. Getting a precise diagnosis can be invaluable for affected families, providing them with a clear understanding of the condition and how to best support their loved one.
The TBR1 gene plays a significant role in brain development and function. Mutations or abnormalities in the TBR1 gene are associated with various forms of intellectual disability, impacting cognitive abilities and development. To identify such genetic variations, the TBR1-Related Genetic Test is a specialized diagnostic tool used to analyze the TBR1 gene for mutations that may contribute to intellectual disabilities.
This test is crucial for early diagnosis and intervention, providing valuable information for managing and supporting individuals with TBR1-related intellectual disabilities. By understanding the genetic basis of these conditions, healthcare providers can offer more personalized and effective treatment plans.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the TBR1-Related Genetic Test is available for a cost of 4400 AED. DNA Labs UAE utilizes state-of-the-art technology and adheres to stringent quality standards, ensuring accurate and reliable results. This test represents a significant step forward in the field of genetic diagnostics, offering hope and insights for affected individuals and their families.
The FLNA Gene Intestinal Pseudoobstruction Neuronal Genetic Test is a specialized diagnostic tool used to identify mutations in the FLNA gene, which are linked to the development of intestinal pseudo-obstruction. This condition is a severe disorder characterized by the symptoms of bowel obstruction without any physical blockage, affecting the patient's ability to digest food and absorb nutrients properly. It is a rare, often debilitating condition that can present from infancy, affecting both males and females, but with a noted severity in males due to the gene's location on the X chromosome.
DNA Labs UAE offers this cutting-edge genetic test, priced at 4400 AED, to patients who exhibit symptoms of intestinal pseudo-obstruction, or have a family history of the disorder, providing a critical tool for accurate diagnosis. By analyzing the patient's DNA, the test can detect mutations in the FLNA gene, enabling healthcare providers to make informed decisions about treatment strategies, manage symptoms more effectively, and offer genetic counseling to affected families. The availability of such a test represents a significant step forward in the personalized treatment of rare genetic disorders, offering hope and improved quality of life to those affected.
The TIMM8A Gene Jensen Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TIMM8A gene, which are associated with Jensen Syndrome. This rare genetic disorder is characterized by deafness, dystonia (a movement disorder), and visual impairment, among other symptoms. The test plays a crucial role in confirming the diagnosis, allowing for early intervention and management strategies to be implemented.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TIMM8A gene. The results can provide valuable information for affected individuals and their families, including insights into the risk of passing the condition to future generations.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by genetic experts, ensuring high accuracy and reliability of the test results. By opting for the TIMM8A Gene Jensen Syndrome Genetic Test, patients and healthcare providers can make informed decisions about treatment options and care plans, improving the quality of life for those affected by the syndrome.
The CCDC88C gene hydrocephalus nonsyndromic autosomal recessive type 1 genetic test is a specialized diagnostic tool designed to identify mutations in the CCDC88C gene, which are linked to a rare form of hydrocephalus. This condition, characterized by an abnormal accumulation of cerebrospinal fluid in the brain's ventricles, can lead to increased intracranial pressure, brain damage, and developmental delays if not properly managed. The test is crucial for families with a history of this condition, offering insights into genetic predispositions and aiding in early intervention strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, this comprehensive test costs 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations associated with nonsyndromic autosomal recessive type 1 hydrocephalus. The results can provide essential information for expecting parents, individuals, or families concerned about the risk of hydrocephalus, enabling informed decisions regarding health management and treatment options.
The "MPDZ Gene Hydrocephalus Nonsyndromic Autosomal Recessive Type 2 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MPDZ gene, which have been linked to the development of nonsyndromic autosomal recessive type 2 hydrocephalus. Hydrocephalus is a condition characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, which can lead to increased intracranial pressure, and in severe cases, brain damage. The condition described as nonsyndromic does not present with other syndromic features, making genetic testing crucial for accurate diagnosis.
The MPDZ gene plays a significant role in cellular functions that are critical for brain development and the regulation of fluid channels, which, when mutated, can disrupt normal CSF flow, leading to hydrocephalus. The genetic test involves analyzing the patient's DNA to detect mutations in the MPDZ gene that are responsible for this specific type of hydrocephalus. This test is particularly important for families with a history of the condition, as it follows an autosomal recessive inheritance pattern, meaning that two copies of the mutated gene (one from each parent) are necessary for a child to be affected.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The test is conducted in their state-of-the-art laboratory facilities, where they utilize the latest in genetic testing technology to ensure accurate and reliable results. This test not only aids in the diagnosis of affected individuals but also provides crucial information for families regarding future pregnancies and the risk of recurrence of the condition. Additionally, early diagnosis through genetic testing can facilitate timely intervention and management of the condition, potentially improving outcomes for those affected.
The GLRA1 Gene Hyperekplexia Genetic Test is a specialized diagnostic tool designed to identify mutations in the GLRA1 gene, which are linked to hyperekplexia, a rare genetic disorder. Hyperekplexia, also known as startle disease, is characterized by an exaggerated startle response to unexpected stimuli. This condition can vary in severity, from mild startles to severe stiffness and falls, and in some cases, it can lead to serious health complications, especially in infants.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic abnormalities in the GLRA1 gene. Identifying mutations in this gene can confirm a diagnosis of hyperekplexia, enabling healthcare providers to offer appropriate treatment and management strategies for the condition.
This specific genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the GLRA1 Gene Hyperekplexia Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a critical step towards personalized medicine for patients exhibiting symptoms of hypereklexia, providing them with a clear diagnosis and paving the way for targeted interventions.
The GLRB gene hyperekplexia genetic test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the GLRB gene, which are associated with hyperekplexia. Hyperekplexia, also known as startle disease, is a rare genetic disorder characterized by an exaggerated startle response to sudden stimuli, muscle stiffness, and, in severe cases, apnea and sudden infant death. This condition is primarily inherited in an autosomal dominant or recessive manner, making the identification of genetic mutations critical for diagnosis, treatment planning, and genetic counseling.
DNA Labs UAE employs cutting-edge genetic sequencing technology to analyze the GLRB gene, ensuring accurate and reliable results. The test is conducted with a simple blood sample or cheek swab, making it non-invasive and straightforward for patients. Upon completion, the results provide essential information regarding the presence of specific gene mutations, aiding in the confirmation of a hyperekplexia diagnosis and facilitating a better understanding of the condition's potential impact on the patient and their family.
The cost of the GLRB gene hyperekplexia genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis and the benefits it brings in terms of targeted treatment and family planning cannot be understated. For families and individuals facing symptoms indicative of hyperekplexia, this test represents a crucial step towards achieving clarity and taking informed actions for managing the condition.
